Skip to main content
. 2022 May 16;8(1):e002301. doi: 10.1136/rmdopen-2022-002301

Figure 2.

Figure 2

Distribution of anti-SARS-CoV-2 IgG antibody levels after the first and second AstraZeneca and Pfizer vaccine doses in the different treatment groups.